A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma
Crossref DOI link: https://doi.org/10.1007/s00280-019-03928-w
Published Online: 2019-08-13
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vornicova, Olga
Haim, Nissim
Bar-Sela, Gil http://orcid.org/0000-0001-6579-1841
Text and Data Mining valid from 2019-08-13
Version of Record valid from 2019-08-13
Article History
Received: 26 May 2019
Accepted: 7 August 2019
First Online: 13 August 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.